Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

医学 临床试验 放射治疗 肿瘤科 内科学 德尔菲法 疾病 医学物理学 重症监护医学 数学 统计
作者
Matthias Gückenberger,Yolande Lievens,Angelique B. Bouma,Laurence Collette,André Dekker,Nandita M. deSouza,Anne‐Marie C. Dingemans,Béatrice Fournier,Coen Hurkmans,Frédéric Lecouvet,Icro Meattini,Alejandra Romero,Umberto Ricardi,Nicola S. Russell,Daniel H. Schanne,Marta Scorsetti,Bertrand Tombal,Dirk Verellen,Christine Verfaillie,Piet Ost
出处
期刊:Lancet Oncology [Elsevier BV]
卷期号:21 (1): e18-e28 被引量:1011
标识
DOI:10.1016/s1470-2045(19)30718-1
摘要

Summary

Oligometastatic disease has been proposed as an intermediate state between localised and systemically metastasised disease. In the absence of randomised phase 3 trials, early clinical studies show improved survival when radical local therapy is added to standard systemic therapy for oligometastatic disease. However, since no biomarker for the identification of patients with true oligometastatic disease is clinically available, the diagnosis of oligometastatic disease is based solely on imaging findings. A small number of metastases on imaging could represent different clinical scenarios, which are associated with different prognoses and might require different treatment strategies. 20 international experts including 19 members of the European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer OligoCare project developed a comprehensive system for characterisation and classification of oligometastatic disease. We first did a systematic review of the literature to identify inclusion and exclusion criteria of prospective interventional oligometastatic disease clinical trials. Next, we used a Delphi consensus process to select a total of 17 oligometastatic disease characterisation factors that should be assessed in all patients treated with radical local therapy for oligometastatic disease, both within and outside of clinical trials. Using a second round of the Delphi method, we established a decision tree for oligometastatic disease classification together with a nomenclature. We agreed oligometastatic disease as the overall umbrella term. A history of polymetastatic disease before diagnosis of oligometastatic disease was used as the criterion to differentiate between induced oligometastatic disease (previous history of polymetastatic disease) and genuine oligometastatic disease (no history of polymetastatic disease). We further subclassified genuine oligometastatic disease into repeat oligometastatic disease (previous history of oligometastatic disease) and de-novo oligometastatic disease (first time diagnosis of oligometastatic disease). In de-novo oligometastatic disease, we differentiated between synchronous and metachronous oligometastatic disease. We did a final subclassification into oligorecurrence, oligoprogression, and oligopersistence, considering whether oligometastatic disease is diagnosed during a treatment-free interval or during active systemic therapy and whether or not an oligometastatic lesion is progressing on current imaging. This oligometastatic disease classification and nomenclature needs to be prospectively evaluated by the OligoCare study.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
彭于晏的应助被缺粥采纳,获得10
2秒前
2秒前
2秒前
cici完成签到,获得积分10
3秒前
3秒前
羊腿完成签到 ,获得积分10
4秒前
TGJ发布了新的文献求助10
4秒前
慕青的应助被ssswww采纳,获得10
4秒前
1210xi完成签到,获得积分10
5秒前
世间安得双全法完成签到,获得积分0
6秒前
Maestro_S完成签到,获得积分0
6秒前
6秒前
6秒前
weqhdgjfk完成签到,获得积分10
6秒前
无头苍蝇完成签到,获得积分10
6秒前
躺平青年阿俊完成签到,获得积分10
6秒前
7秒前
st完成签到,获得积分10
7秒前
jzhou65完成签到,获得积分10
8秒前
8秒前
sense发布了新的文献求助10
9秒前
花花完成签到,获得积分10
9秒前
9秒前
9秒前
CC66发布了新的文献求助10
10秒前
10秒前
捞鱼完成签到,获得积分10
11秒前
11秒前
11秒前
ssswww完成签到,获得积分10
11秒前
张志辉完成签到,获得积分10
11秒前
薛小飞发布了新的文献求助10
12秒前
dent强完成签到,获得积分10
12秒前
无限紫槐发布了新的文献求助10
13秒前
ddd发布了新的文献求助10
13秒前
古语发布了新的文献求助10
13秒前
66发布了新的文献求助10
14秒前
烟花的应助被cxy采纳,获得10
14秒前
Shirly完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190478
求助须知:如何正确求助?哪些是违规求助? 9577686
关于积分的说明 21853808
捐赠科研通 7789496
什么是DOI,文献DOI怎么找? 3436407
关于科研通互助平台的介绍 2560235
邀请新用户注册赠送积分活动 2483054